A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
2023-11-28 06:27
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
You Might Like...
iPhone event: Everything Apple is expect to reveal at major ‘wonderlust’ launch
Electron Founder Jos Shaver Steps Down From $3 Billion Hedge Fund
Get a smart scale that tracks 11 body metrics for $28
Massive amount of rare rock discovered which could power batteries for next century
Appeals Court Refuses to Allow US to Limit Oil Drilling Auction
iPhone 14 and Pro: Apple users say their phone batteries are running down unexpectedly quickly
Making Solar Panels Is 'Horrible' Business. The US Still Wants It.
Amazon’s Answer to ChatGPT Seen as Incomplete